The aim of our study was to evaluate the effectivenessof clozapine and olanzapine in the treatment of schizophrenicpatients. Either clozapine or olanzapine signifcantly ameliorated positive symptoms, but only clozapine was effective in reducinganxiety and hallucinations, while olanzapine was more effective in reducing negative symptoms, such as mannerism and posturing, blunted affect and emotional withdrawal. Olanzapine-treated patients obtained significantly higher GAF scores than clozapine-treated patients and more frequently participated in rehabilitative programmes. In conclusio, olanzapine therapy has surprisingly been shown to be more effective than clozapine in improving social and working skills
A recent increase in the literature regarding the evidence base for clozapine has made it increasing...
Background: Schizophrenia is a functional psychosis with severe personality changes and thought diso...
There is good evidence that clozapine is more efficacious than first-generation antipsychotic drugs ...
The treatment of schizophrenic patients who fail to respond to adequate trials of neuroleptic drugs ...
OBJECTIVE: Antipsychotic medications may reduce hostile and aggressive behavior in schizophrenia. Th...
Introduction. The present study aims to evaluate effectiveness of antipsychotics in a cohort of chro...
The efficacy and side effects of olanzapine (an atypical antipsychotic) for the treatment of Schizop...
Background: Schizophrenia is one of the most commonly encountered psychiatric disorders. It is chara...
AIM: To record any evidence of a treatment effect with olanzapine in patients who had been withdrawn...
Schizophrenia is a chronic psychotic disorder characterized by the presence of psychotic symptoms (h...
BACKGROUND: Psychotic depression is more common than is generally realized, occurring in an estimate...
Introduction: The cognitive effects of antipsychotic drugs represent a potential exploratory tool wi...
Therapy-resistance for positive symptoms is one of the most important problems that occurs with the ...
Improved drug therapy for schizophrenia may represent the best strategy for reducing the costs of sc...
Background Between 40% and 70% of people with treatment-resistant schizophrenia do not respond to c...
A recent increase in the literature regarding the evidence base for clozapine has made it increasing...
Background: Schizophrenia is a functional psychosis with severe personality changes and thought diso...
There is good evidence that clozapine is more efficacious than first-generation antipsychotic drugs ...
The treatment of schizophrenic patients who fail to respond to adequate trials of neuroleptic drugs ...
OBJECTIVE: Antipsychotic medications may reduce hostile and aggressive behavior in schizophrenia. Th...
Introduction. The present study aims to evaluate effectiveness of antipsychotics in a cohort of chro...
The efficacy and side effects of olanzapine (an atypical antipsychotic) for the treatment of Schizop...
Background: Schizophrenia is one of the most commonly encountered psychiatric disorders. It is chara...
AIM: To record any evidence of a treatment effect with olanzapine in patients who had been withdrawn...
Schizophrenia is a chronic psychotic disorder characterized by the presence of psychotic symptoms (h...
BACKGROUND: Psychotic depression is more common than is generally realized, occurring in an estimate...
Introduction: The cognitive effects of antipsychotic drugs represent a potential exploratory tool wi...
Therapy-resistance for positive symptoms is one of the most important problems that occurs with the ...
Improved drug therapy for schizophrenia may represent the best strategy for reducing the costs of sc...
Background Between 40% and 70% of people with treatment-resistant schizophrenia do not respond to c...
A recent increase in the literature regarding the evidence base for clozapine has made it increasing...
Background: Schizophrenia is a functional psychosis with severe personality changes and thought diso...
There is good evidence that clozapine is more efficacious than first-generation antipsychotic drugs ...